Posted on 12/10/2021 8:30:31 AM PST by Nifty
An industry is born
By the late 2000s, several big pharmaceutical companies were entering the mRNA field. In 2008, for example, both Novartis and Shire established mRNA research units — the former (led by Geall) focused on vaccines, the latter (led by Heartlein) on therapeutics. BioNTech launched that year, and other start-ups soon entered the fray, bolstered by a 2012 decision by the US Defense Advanced Research Projects Agency to start funding industry researchers to study RNA vaccines and drugs. Moderna was one of the companies that built on this work and, by 2015, it had raised more than $1 billion on the promise of harnessing mRNA to induce cells in the body to make their own medicines — thereby fixing diseases caused by missing or defective proteins. When that plan faltered, Moderna, led by chief executive Stéphane Bancel, chose to prioritize a less ambitious target: making vaccines.
(Excerpt) Read more at nature.com ...
they had this huge investment just sitting on the shelf
and along comes the plandemic
***
The article makes no mention of weaponizing MRNA. NATO tried for twenty years to develop a virus that could target certain DNA. They stopped the R and D due to being very risky and deadly. Recently, DOD claims North Korea and China have not given up developing DNA targeting weapons.
Yet China is tied to the testing companies to acquire everyone’s DNA from the swabs - the LA County Sheriff will not work with the testing company that LA made a deal with
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.